Polyrizon (PLRZ) announced that it has signed a non-binding Letter of Intent with a biotech company focused on psychedelic-derived ...
Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...
Polyrizon Ltd. (Nasdaq: PLRZ) (the 'Company” or 'Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today that it has signed ...
This collaboration emphasizes the growing potential of intranasal drug delivery in the psychedelic medicine space, offering an innovative approach to enhancing bioavailability, efficacy ...
An asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Tezepelumab was first ...
New York-based Ascent Consumer Products Inc. has issued a voluntary recall of one lot of SinuCleanse Soft Tip Squeeze Bottle ...
Phenylephrine and pseudoephedrine are both active ingredients in nonprescription Sudafed products. However, phenylephrine has ...
Breathing is essential to our daily lives, yet many people struggle with nasal congestion that can disrupt sleep, exercise, and overall well-being. For those searching for a solution, Air Aid Nose ...
An asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Tezepelumab was first approved for treating asthma in 2021, but new research led by a University ...
An asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Tezepelumab was first ...
It is being recalled because it could be contaminated with Staphylococcus aureus, which causes staph infections.